These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24989713)

  • 21. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
    Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
    Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-factor VIII inhibitors and lupus anticoagulants in haemophilia A patients.
    Blanco AN; Cardozo MA; Candela M; Santarelli MT; Pérez Bianco R; Lazzari MA
    Thromb Haemost; 1997 Apr; 77(4):656-9. PubMed ID: 9134638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma Antiphospholipid Antibodies Effects on Activated Partial Thromboplastin Time Assays.
    Yao K; Zhang L; Zhou H; Tang N; Li D
    Am J Med Sci; 2017 Jul; 354(1):22-26. PubMed ID: 28755727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acquired hemophilia A after an early abortion].
    Wullen B; Mühlhöfer A; Luz H; Zoller WG
    Dtsch Med Wochenschr; 2002 May; 127(20):1075-8. PubMed ID: 12016555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applying a direct aPTT ratio (PlatelinLS/ActinFS) permits to identify rapidly and reliably a bleeding-related factor deficiency or a lupus anticoagulant sequential to an isolated prolongation of aPTT in paediatric pre-operative screening.
    Li R; Swaelens C; Vandermijnsbrugge F; Cantinieaux B
    Eur J Haematol; 2016 Jun; 96(6):578-85. PubMed ID: 26179977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lupus anticoagulant-hypoprothrombinemia syndrome and immunoglobulin-A vasculitis: a report of Japanese sibling cases and review of the literature.
    Fujiwara K; Shimizu J; Tsukahara H; Shimada A
    Rheumatol Int; 2019 Oct; 39(10):1811-1819. PubMed ID: 31392497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Evaluation of the Activated Partial Thromboplastin Time Waveform.
    Matsumoto T; Wada H; Fujimoto N; Toyoda J; Abe Y; Ohishi K; Yamashita Y; Ikejiri M; Hasegawa K; Suzuki K; Imai H; Nakatani K; Katayama N
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):764-770. PubMed ID: 28884611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
    Chng WJ; Sum C; Kuperan P
    Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interference of factor VIII excess on the detection of lupus anticoagulants by the activated partial thromboplastin time].
    Guermazi S; Gorgi Y; Ayed K; Dellagi K
    Pathol Biol (Paris); 1997 Jan; 45(1):28-33. PubMed ID: 9097843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy of silica clotting time method for lupus anticoagulant in a clinical population with various symptoms of antiphospholipid syndrome.
    Averina M; Johannesen S; Brox J
    Lupus; 2016 Apr; 25(4):418-22. PubMed ID: 26612052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lupus anticoagulant-hypoprothrombinemia syndrome presenting with co-existing cerebral venous thrombosis and subdural hemorrhage.
    Bel Feki N; Zayet S; Ben Ghorbel I; Houman MH
    J Mal Vasc; 2016 Dec; 41(6):403-406. PubMed ID: 27743753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antiphospholipid antibodies in asymptomatic pediatric patients].
    Aguilar Franco C; Lucía Cuesta J
    An Esp Pediatr; 2001 May; 54(5):444-9. PubMed ID: 11333473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation.
    Jennings I; Kitchen S; Woods TA; Preston FE; Greaves M
    Thromb Haemost; 1997 May; 77(5):934-7. PubMed ID: 9184405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines.
    Swadzba J; Iwaniec T; Pulka M; De Laat B; De Groot PG; Musial J
    J Thromb Haemost; 2011 Sep; 9(9):1776-83. PubMed ID: 21707912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lupus anticoagulant increases activated partial thromboplastin time (PTT) prolongation in incubated 1:1 mix.
    Monis G; Ferrell C; Reyes M
    Clin Lab Sci; 2012; 25(3):165-9. PubMed ID: 22953516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Systemic lupus erythematosus with acquired hemophilia A: a case report].
    Yang F; Zhou YS; Jia Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1108-1111. PubMed ID: 30562791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The antiphospholipid syndrome during chronic lymphatic leukemia. An association with anti-factor VIII antibodies].
    Ghirarduzzi A; Silingardi M; D'Incà M; Tincani E
    Ann Ital Med Int; 1999; 14(1):46-50. PubMed ID: 10528424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and Measurement of Factor Inhibitors.
    Kershaw G
    Methods Mol Biol; 2017; 1646():295-304. PubMed ID: 28804837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The challenges of lupus anticoagulants.
    Chighizola CB; Raschi E; Banzato A; Borghi MO; Pengo V; Meroni PL
    Expert Rev Hematol; 2016; 9(4):389-400. PubMed ID: 26789237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevalence of prolonged APTT and lupus anticoagulant in autoimmune thyroid disease].
    Tani Y; Morita M; Noguchi S
    Rinsho Byori; 1997 Sep; 45(9):899-902. PubMed ID: 9311265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.